OXY three-lens brief
Evidence-based stock research on OXY. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 27.2pp over 30 days. · P/E of 76 — priced for high growth; little margin of safety.
- Underperforming SPY by 27.2pp over 30 days.
- P/E of 76 — priced for high growth; little margin of safety.
- Debt-to-equity of 63.8 — balance-sheet-heavy.
OXY closed at $55.97 (-0.53%) as of 2026-05-13. Market cap: $55.67B. P/E (trailing) 75.6. Concerns: underperforming SPY by 27.2pp over 30 days.; p/E of 76 — priced for high growth; little margin of safety.. Last quarter: Revenue $5.42B, net income -$68.00M, free cash flow $2.05B.
Why three lenses on OXY, not one.
A single reasoning model has blind spots it doesn’t know about. We examine OXYacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/OXY" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath OXY brief"></iframe>